US Patent Issued to Northwestern University on Sept. 16 for "Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin" (Illinois Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,963, issued on Sept. 16, was assigned to Northwestern University (Evanston, Ill.).

"Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin" was invented by Kazuhiro Shimomura (Wilmette, Ill.), Martha Hotz Vitaterna (Northbrook, Ill.) and Phyllis C. Zee (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compositions and methods of treating a sleep-wake disorder or neurodegenerative diseases using modified resistant maltodextrin."

The patent was filed on May 31, 2022, under Application No. 17/828,758.

*For further information, including images, charts and tables, plea...